Gene expression profiling (GEP) to predict the primary site of metastatic neuroendocrine tumors (NETs) presenting with an unknown primary.
Eugene Woltering
No relevant relationships to disclose
Lowell Brian Anthony
Consultant or Advisory Role - bioTheranostics
Anne E. Diebold
No relevant relationships to disclose
J Philip Boudreaux
No relevant relationships to disclose
Yi-Zarn Wang
No relevant relationships to disclose